CY1111871T1 - Υποκατεστημενα βενζιμιδαζολια και μεθοδοι παρασκευης - Google Patents
Υποκατεστημενα βενζιμιδαζολια και μεθοδοι παρασκευηςInfo
- Publication number
- CY1111871T1 CY1111871T1 CY20111100607T CY111100607T CY1111871T1 CY 1111871 T1 CY1111871 T1 CY 1111871T1 CY 20111100607 T CY20111100607 T CY 20111100607T CY 111100607 T CY111100607 T CY 111100607T CY 1111871 T1 CY1111871 T1 CY 1111871T1
- Authority
- CY
- Cyprus
- Prior art keywords
- preparation
- methods
- substituted benzimidazoles
- formula
- benzimidazoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Παρέχεται μέθοδος για παρασκευή νέων υποκατεστημένων ενώσεων βενζιμιδαζολίου που έχουν το συντακτικό τύπο (I) χρήσιμων για θεραπεία διαταραχών που προκαλούνται από κινάση όπου τα R1, R2, R3, R4 a, b, και c ορίζονται εδώ στον συνταντικό τύπο (I).
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71253905P | 2005-08-30 | 2005-08-30 | |
US71310805P | 2005-08-30 | 2005-08-30 | |
US73159105P | 2005-10-27 | 2005-10-27 | |
US77468406P | 2006-02-17 | 2006-02-17 | |
EP06790127A EP1924577B1 (en) | 2005-08-30 | 2006-08-30 | Substituted benzimidazoles and methods of preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1111871T1 true CY1111871T1 (el) | 2015-11-04 |
Family
ID=37434025
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20111100607T CY1111871T1 (el) | 2005-08-30 | 2011-06-27 | Υποκατεστημενα βενζιμιδαζολια και μεθοδοι παρασκευης |
CY20111101214T CY1112157T1 (el) | 2005-08-30 | 2011-12-06 | Υποκαθιστουμενες βενζιμιδαζολες ως αναστολεις κινασης |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20111101214T CY1112157T1 (el) | 2005-08-30 | 2011-12-06 | Υποκαθιστουμενες βενζιμιδαζολες ως αναστολεις κινασης |
Country Status (37)
Country | Link |
---|---|
US (6) | US20070049622A1 (el) |
EP (2) | EP1926722B1 (el) |
JP (4) | JP5210867B2 (el) |
KR (2) | KR20080039964A (el) |
AR (2) | AR057109A1 (el) |
AT (2) | ATE503751T1 (el) |
AU (2) | AU2006287688B2 (el) |
BR (2) | BRPI0615309B1 (el) |
CA (2) | CA2619966A1 (el) |
CR (1) | CR9716A (el) |
CU (1) | CU23784B7 (el) |
CY (2) | CY1111871T1 (el) |
DE (1) | DE602006021036D1 (el) |
DK (2) | DK1924577T3 (el) |
EA (1) | EA014230B1 (el) |
EC (2) | ECSP088210A (el) |
ES (1) | ES2374451T3 (el) |
GE (1) | GEP20105004B (el) |
GT (1) | GT200600394A (el) |
HK (2) | HK1117519A1 (el) |
HN (1) | HN2008000317A (el) |
HR (2) | HRP20110312T1 (el) |
IL (2) | IL189080A (el) |
MA (2) | MA29915B1 (el) |
MY (2) | MY163886A (el) |
NI (1) | NI200800060A (el) |
NO (1) | NO20081476L (el) |
NZ (2) | NZ565451A (el) |
PE (2) | PE20070427A1 (el) |
PL (2) | PL1924577T3 (el) |
PT (2) | PT1924577E (el) |
RS (1) | RS52099B (el) |
SI (2) | SI1926722T1 (el) |
SM (1) | SMAP200800022A (el) |
TN (2) | TNSN08089A1 (el) |
TW (2) | TWI387592B (el) |
WO (2) | WO2007030377A1 (el) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI387592B (zh) * | 2005-08-30 | 2013-03-01 | Novartis Ag | 經取代之苯并咪唑及其作為與腫瘤形成相關激酶之抑制劑之方法 |
GB0609378D0 (en) * | 2006-05-11 | 2006-06-21 | Novartis Ag | Organic compounds |
JP2009544617A (ja) * | 2006-07-21 | 2009-12-17 | ノバルティス アクチエンゲゼルシャフト | ベンゾイミダゾリルピリジルエーテルの製剤 |
PE20080766A1 (es) * | 2006-08-30 | 2008-06-15 | Novartis Ag | Sales de benzimidazolil piridil eteres y formulaciones que las contienen |
EP2074226A2 (en) * | 2006-09-19 | 2009-07-01 | Novartis AG | Biomarkers of target modulation, efficacy, diagnosis and/or prognosis for raf inhibitors |
EP2132198A1 (en) * | 2007-03-02 | 2009-12-16 | Novartis Ag | Solid forms of a raf kinase inhibitor |
CN101674828A (zh) * | 2007-05-23 | 2010-03-17 | 诺瓦提斯公司 | 用于治疗甲状腺癌的Raf抑制剂 |
US8304557B2 (en) | 2007-06-05 | 2012-11-06 | Takeda Pharmaceutical Company Limited | Fused heterocycle derivatives and use thereof |
JP5270553B2 (ja) | 2007-08-23 | 2013-08-21 | 武田薬品工業株式会社 | 複素環化合物およびその用途 |
WO2009028629A1 (ja) * | 2007-08-29 | 2009-03-05 | Takeda Pharmaceutical Company Limited | 複素環化合物およびその用途 |
US20110092546A1 (en) * | 2008-06-13 | 2011-04-21 | Novartis Ag | Substituted benzimidazoles for neurofibromatosis |
MX2011000440A (es) * | 2008-07-11 | 2011-02-24 | Novartis Ag | Combinacion de (a) un inhibidor de fosfoinositido 3-cinasa y (b) un modulador de la ruta de ras/raf/mek. |
MX2011004505A (es) * | 2008-10-29 | 2011-05-31 | Merck Sharp & Dohme | Derivados novedosos de bencimidazol ciclico, utiles como agentes antidiabeticos. |
EP2399921B1 (en) | 2008-12-01 | 2015-08-12 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
JO3101B1 (ar) | 2008-12-02 | 2017-09-20 | Takeda Pharmaceuticals Co | مشتقات بنزوثيازول كعوامل مضادة للسرطان |
JP2011020936A (ja) * | 2009-07-14 | 2011-02-03 | Lotte Co Ltd | 口臭除去剤 |
AR077975A1 (es) | 2009-08-28 | 2011-10-05 | Irm Llc | Derivados de pirazol pirimidina y composiciones como inhibidores de cinasa de proteina |
WO2011044072A1 (en) | 2009-10-05 | 2011-04-14 | Novartis Ag | Combination of raf-265 and an activator of ampk for use in the treatment of a proliferative disease |
JP2013543008A (ja) * | 2010-11-19 | 2013-11-28 | グラクソスミスクライン、インテレクチュアル、プロパティー、ナンバー2、リミテッド | Braf阻害剤による治療方法 |
CA2828946C (en) | 2011-04-18 | 2016-06-21 | Eisai R&D Management Co., Ltd. | Therapeutic agent for tumor |
WO2012145503A1 (en) | 2011-04-21 | 2012-10-26 | Novartis Ag | Pharmaceutical combinations |
AU2012333092B2 (en) | 2011-08-31 | 2016-04-21 | Novartis Ag | Synergistic combinations of PI3K- and MEK-inhibitors |
RU2641693C2 (ru) * | 2011-11-09 | 2018-01-22 | Кансер Ресёрч Текнолоджи Лимитед | Соединения 5-(пиридин-2-иламино)-пиразин-2-карбонитрила и их терапевтическое применение |
CA2855243C (en) | 2011-11-11 | 2020-04-14 | Novartis Ag | Method of treating a proliferative disease |
LT2782557T (lt) | 2011-11-23 | 2018-12-27 | Array Biopharma, Inc. | Farmacinės kompozicijos |
RU2659786C2 (ru) | 2012-05-15 | 2018-07-04 | Кансер Ресёрч Текнолоджи Лимитед | 5-[[4-[[морфолин-2-ил]метиламино]-5-(трифторметил)-2-пиридил]амино]пиразин-2-карбонитрил, его терапевтические применения |
US20150283136A1 (en) | 2012-11-08 | 2015-10-08 | Novartis Ag | Pharmaceutical combination comprising a b-raf inhibitor and a histone deacetylase inhibitor and their use in the treatment of proliferative diseases |
MX2015013466A (es) | 2013-03-21 | 2016-06-21 | Novartis Ag | Terapia de combinacion que comprende un inhibidor deb-raf y un segundo inhibidor. |
WO2015041534A1 (en) | 2013-09-20 | 2015-03-26 | Stichting Het Nederlands Kanker Instituut | P90rsk in combination with raf/erk/mek |
US9629851B2 (en) | 2013-09-20 | 2017-04-25 | Stitching Het Nederlands Kanker Institut—Antoni Van Leeuwenhoek Ziekenhuis | ROCK in combination with MAPK pathway |
JOP20200094A1 (ar) | 2014-01-24 | 2017-06-16 | Dana Farber Cancer Inst Inc | جزيئات جسم مضاد لـ pd-1 واستخداماتها |
JOP20200096A1 (ar) | 2014-01-31 | 2017-06-16 | Children’S Medical Center Corp | جزيئات جسم مضاد لـ tim-3 واستخداماتها |
US20150259420A1 (en) | 2014-03-14 | 2015-09-17 | Novartis Ag | Antibody molecules to lag-3 and uses thereof |
WO2015156674A2 (en) | 2014-04-10 | 2015-10-15 | Stichting Het Nederlands Kanker Instituut | Method for treating cancer |
WO2015178770A1 (en) | 2014-05-19 | 2015-11-26 | Stichting Het Nederlands Kanker Instituut | Compositions for cancer treatment |
MA41044A (fr) | 2014-10-08 | 2017-08-15 | Novartis Ag | Compositions et procédés d'utilisation pour une réponse immunitaire accrue et traitement contre le cancer |
BR112017007379A2 (pt) | 2014-10-14 | 2017-12-19 | Dana Farber Cancer Inst Inc | moléculas de anticorpo para pd-l1 e usos das mesmas |
WO2016100882A1 (en) | 2014-12-19 | 2016-06-23 | Novartis Ag | Combination therapies |
WO2016145102A1 (en) | 2015-03-10 | 2016-09-15 | Aduro Biotech, Inc. | Compositions and methods for activating "stimulator of interferon gene" -dependent signalling |
US9890187B2 (en) | 2015-06-26 | 2018-02-13 | Epos-Iasis Research And Development, Ltd. | Prototype systems of theranostic biomarkers for in vivo molecular management of cancer |
LT3316856T (lt) | 2015-06-30 | 2021-07-12 | Sequessome Technology Holdings Limited | Mišrios kompozicijos |
PL3317301T3 (pl) | 2015-07-29 | 2021-11-15 | Novartis Ag | Terapie skojarzone zawierające cząsteczki przeciwciał przeciw lag-3 |
EP3316902A1 (en) | 2015-07-29 | 2018-05-09 | Novartis AG | Combination therapies comprising antibody molecules to tim-3 |
EP3328418A1 (en) | 2015-07-29 | 2018-06-06 | Novartis AG | Combination therapies comprising antibody molecules to pd-1 |
KR20180069070A (ko) | 2015-11-03 | 2018-06-22 | 얀센 바이오테크 인코포레이티드 | Tim-3과 특이적으로 결합하는 항체 및 그의 용도 |
CN105481944B (zh) * | 2015-12-10 | 2019-01-08 | 华南农业大学 | 一种苯并咪唑衍生物二肽铜配合物及其制备方法和应用 |
CN108495651A (zh) | 2015-12-17 | 2018-09-04 | 诺华股份有限公司 | 抗pd-1的抗体分子及其用途 |
US11098077B2 (en) | 2016-07-05 | 2021-08-24 | Chinook Therapeutics, Inc. | Locked nucleic acid cyclic dinucleotide compounds and uses thereof |
JP7341060B2 (ja) | 2017-02-10 | 2023-09-08 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | Mapk経路の活性化に関連付けられる癌の処置のための方法及び医薬組成物 |
US11242332B2 (en) | 2017-03-15 | 2022-02-08 | Sumitomo Dainippon Pharma Co., Ltd. | Method for producing benzimidazole derivative |
CN110831927B (zh) | 2017-04-18 | 2023-07-14 | 礼来公司 | 苯基-2-羟基-乙酰氨基-2-甲基-苯基化合物 |
UY37695A (es) | 2017-04-28 | 2018-11-30 | Novartis Ag | Compuesto dinucleótido cíclico bis 2’-5’-rr-(3’f-a)(3’f-a) y usos del mismo |
CN118307674A (zh) | 2017-06-22 | 2024-07-09 | 诺华股份有限公司 | 针对cd73的抗体分子及其用途 |
EP3642240A1 (en) | 2017-06-22 | 2020-04-29 | Novartis AG | Antibody molecules to cd73 and uses thereof |
WO2019133810A1 (en) | 2017-12-28 | 2019-07-04 | Tract Pharmaceuticals, Inc. | Stem cell culture systems for columnar epithelial stem cells, and uses related thereto |
AR126019A1 (es) | 2018-05-30 | 2023-09-06 | Novartis Ag | Anticuerpos frente a entpd2, terapias de combinación y métodos de uso de los anticuerpos y las terapias de combinación |
WO2019232244A2 (en) | 2018-05-31 | 2019-12-05 | Novartis Ag | Antibody molecules to cd73 and uses thereof |
EP3876930A4 (en) * | 2018-11-07 | 2022-07-20 | Dana-Farber Cancer Institute, Inc. | BENZIMIDAZOLE DERIVATIVES AND AZA-BENZIMIDAZOLE DERIVATIVES AS JANUS KINASE 2 INHIBITORS AND THEIR USES |
US11976052B2 (en) | 2019-01-11 | 2024-05-07 | Naegis Pharmaceuticals Inc. | Leukotriene synthesis inhibitors |
JP2022548881A (ja) | 2019-09-18 | 2022-11-22 | ノバルティス アーゲー | Entpd2抗体、組合せ療法並びに抗体及び組合せ療法を使用する方法 |
JP2023525047A (ja) | 2020-05-06 | 2023-06-14 | エイジャックス セラピューティクス, インコーポレイテッド | Jak2阻害薬としての6-ヘテロアリールオキシベンゾイミダゾール及びアザベンゾイミダゾール |
TW202334139A (zh) | 2021-11-09 | 2023-09-01 | 美商雅捷可斯治療公司 | 作為jak2抑制劑之6-雜芳氧基苯并咪唑及氮雜苯并咪唑 |
Family Cites Families (131)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3894037A (en) | 1971-05-24 | 1975-07-08 | Ciba Geigy Corp | Certain isothiocyanobenzimidazoles |
US4197307A (en) | 1977-04-12 | 1980-04-08 | Ciba-Geigy Corporation | 2-Alkylthio-, 2-alkylsulphinyl- and 2-alkylsulfonyl-6-phenylbenzimidazoles as anthelmintic agents |
US4319039A (en) | 1979-06-15 | 1982-03-09 | Merck & Co., Inc. | Preparation of ammonium salt of hypocholesteremic fermentation product |
US4231938A (en) | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
US4294926A (en) | 1979-06-15 | 1981-10-13 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
US4444784A (en) | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
MX7065E (es) | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
JPS5889191A (ja) | 1981-11-20 | 1983-05-27 | Sankyo Co Ltd | 3−ヒドロキシ−ml−236b誘導体の製造法 |
US4430502A (en) | 1982-08-13 | 1984-02-07 | The Upjohn Company | Pyridinyl substituted benzimidazoles and quinoxalines |
US5354772A (en) | 1982-11-22 | 1994-10-11 | Sandoz Pharm. Corp. | Indole analogs of mevalonolactone and derivatives thereof |
US4911165A (en) | 1983-01-12 | 1990-03-27 | Ethicon, Inc. | Pliabilized polypropylene surgical filaments |
GB8307865D0 (en) | 1983-03-22 | 1983-04-27 | Fujisawa Pharmaceutical Co | Benzimidazole derivatives |
US4681893A (en) | 1986-05-30 | 1987-07-21 | Warner-Lambert Company | Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis |
US4885314A (en) | 1987-06-29 | 1989-12-05 | Merck & Co., Inc. | Novel HMG-CoA reductase inhibitors |
US4782084A (en) | 1987-06-29 | 1988-11-01 | Merck & Co., Inc. | HMG-COA reductase inhibitors |
US4820850A (en) | 1987-07-10 | 1989-04-11 | Merck & Co., Inc. | Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof |
US5030447A (en) | 1988-03-31 | 1991-07-09 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions having good stability |
US5180589A (en) | 1988-03-31 | 1993-01-19 | E. R. Squibb & Sons, Inc. | Pravastatin pharmaceuatical compositions having good stability |
US4916239A (en) | 1988-07-19 | 1990-04-10 | Merck & Co., Inc. | Process for the lactonization of mevinic acids and analogs thereof |
US5118853A (en) | 1988-10-13 | 1992-06-02 | Sandoz Ltd. | Processes for the synthesis of 3-disubstituted aminoacroleins |
US5290946A (en) | 1988-10-13 | 1994-03-01 | Sandoz Ltd. | Processes for the synthesis of 3-(substituted indolyl-2-yl)propenaldehydes |
US4929437A (en) | 1989-02-02 | 1990-05-29 | Merck & Co., Inc. | Coenzyme Q10 with HMG-CoA reductase inhibitors |
US5189164A (en) | 1989-05-22 | 1993-02-23 | Sandoz Ltd. | Processes for the synthesis of syn-(E)-3,5-dihydroxy-7-substituted hept-6-enoic and heptanoic acids and derivatives and intermediates thereof |
FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
PH27357A (en) | 1989-09-22 | 1993-06-21 | Fujisawa Pharmaceutical Co | Pyrazole derivatives and pharmaceutical compositions comprising the same |
JPH06759B2 (ja) | 1989-09-22 | 1994-01-05 | ファイザー製薬株式会社 | 新規なベンゾイミダゾール化合物 |
US5420245A (en) | 1990-04-18 | 1995-05-30 | Board Of Regents, The University Of Texas | Tetrapeptide-based inhibitors of farnesyl transferase |
US5041453A (en) | 1990-05-30 | 1991-08-20 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene D4 |
FR2677020B1 (fr) | 1991-05-31 | 1993-08-27 | Cird Galderma | Composes derives de benzimidazole, leur procede de preparation et leur utilisation dans les domaines therapeutique et cosmetique. |
HU9203780D0 (en) | 1991-12-12 | 1993-03-29 | Sandoz Ag | Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them |
US5612360A (en) | 1992-06-03 | 1997-03-18 | Eli Lilly And Company | Angiotensin II antagonists |
US5604260A (en) | 1992-12-11 | 1997-02-18 | Merck Frosst Canada Inc. | 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 |
EP0604181A1 (en) | 1992-12-21 | 1994-06-29 | Eli Lilly And Company | Antitumor compositions and method of treatment |
US5298627A (en) | 1993-03-03 | 1994-03-29 | Warner-Lambert Company | Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
US5409944A (en) | 1993-03-12 | 1995-04-25 | Merck Frosst Canada, Inc. | Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase |
CA2118985A1 (en) | 1993-04-02 | 1994-10-03 | Dinesh V. Patel | Heterocyclic inhibitors of farnesyl protein transferase |
AU6909194A (en) | 1993-05-14 | 1994-12-12 | Board Of Regents, The University Of Texas System | Preparation of n-cyanodithioimino-carbonates and 3-mercapto-5-amino-1h-1,2,4-triazole |
US5602098A (en) | 1993-05-18 | 1997-02-11 | University Of Pittsburgh | Inhibition of farnesyltransferase |
US5380738A (en) | 1993-05-21 | 1995-01-10 | Monsanto Company | 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents |
GB9602877D0 (en) | 1996-02-13 | 1996-04-10 | Merck Frosst Canada Inc | 3,4-Diaryl-2-hydroxy-2,5- dihydrofurans as prodrugs to cox-2 inhibitors |
US5474995A (en) | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
US5436265A (en) | 1993-11-12 | 1995-07-25 | Merck Frosst Canada, Inc. | 1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents |
US5852046A (en) | 1993-08-03 | 1998-12-22 | Hoechst Aktiengesellschaft | Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them |
EP0639573A1 (de) | 1993-08-03 | 1995-02-22 | Hoechst Aktiengesellschaft | Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament |
US5661152A (en) | 1993-10-15 | 1997-08-26 | Schering Corporation | Tricyclic sulfonamide compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
US5344991A (en) | 1993-10-29 | 1994-09-06 | G.D. Searle & Co. | 1,2 diarylcyclopentenyl compounds for the treatment of inflammation |
US5466823A (en) | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
US5484799A (en) | 1993-12-09 | 1996-01-16 | Abbott Laboratories | Antifungal dorrigocin derivatives |
US5393790A (en) | 1994-02-10 | 1995-02-28 | G.D. Searle & Co. | Substituted spiro compounds for the treatment of inflammation |
IL113196A0 (en) | 1994-03-31 | 1995-06-29 | Bristol Myers Squibb Co | Imidazole derivatives and pharmaceutical compositions containing the same |
US5523430A (en) | 1994-04-14 | 1996-06-04 | Bristol-Myers Squibb Company | Protein farnesyl transferase inhibitors |
US5510510A (en) | 1994-05-10 | 1996-04-23 | Bristol-Meyers Squibb Company | Inhibitors of farnesyl protein transferase |
US6358932B1 (en) | 1994-05-31 | 2002-03-19 | Isis Pharmaceticals, Inc. | Antisense oligonucleotide inhibition of raf gene expression |
US6391636B1 (en) | 1994-05-31 | 2002-05-21 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of raf gene expression |
US5571792A (en) | 1994-06-30 | 1996-11-05 | Warner-Lambert Company | Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
CA2155448A1 (en) | 1994-08-11 | 1996-02-12 | Katerina Leftheris | Inhibitors of farnesyl protein transferase |
EP0701907A1 (en) | 1994-09-13 | 1996-03-20 | Agfa-Gevaert N.V. | A dye donor element for use in a thermal dye transfer process |
US6037136A (en) | 1994-10-24 | 2000-03-14 | Cold Spring Harbor Laboratory | Interactions between RaF proto-oncogenes and CDC25 phosphatases, and uses related thereto |
US5741789A (en) | 1995-01-17 | 1998-04-21 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
US5633272A (en) | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
US6001866A (en) | 1995-10-05 | 1999-12-14 | Warner-Lambert Company | Method for treating and preventing inflammation and atherosclerosis |
US5717100A (en) | 1995-10-06 | 1998-02-10 | Merck & Co., Inc. | Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
US6020343A (en) | 1995-10-13 | 2000-02-01 | Merck Frosst Canada, Inc. | (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors |
ATE218556T1 (de) | 1995-11-17 | 2002-06-15 | Biotechnolog Forschung Gmbh | Epothilon-derivate und deren herstellung |
US6166219A (en) | 1995-12-28 | 2000-12-26 | Fujisawa Pharmaceutical Co., Ltd. | Benzimidazole derivatives |
GB9602029D0 (en) | 1996-02-01 | 1996-04-03 | Fujisawa Pharmaceutical Co | New heterocyclic compounds |
CA2249009C (en) | 1996-04-12 | 2003-09-16 | G.D. Searle & Co. | Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
CA2256109A1 (en) | 1996-05-23 | 1997-11-27 | Applied Research Systems Ars Holding N.V. | Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same |
US5861419A (en) | 1996-07-18 | 1999-01-19 | Merck Frosst Canad, Inc. | Substituted pyridines as selective cyclooxygenase-2 inhibitors |
FR2751649B1 (fr) | 1996-07-26 | 1998-08-28 | Adir | Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
WO1999001124A1 (en) | 1996-12-03 | 1999-01-14 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
US6127380A (en) | 1997-02-18 | 2000-10-03 | American Home Products Corporation | 4-aminoalkoxy-1H-benzoimidazoles |
US5932600A (en) | 1997-03-14 | 1999-08-03 | Vertex Pharmaceuticals Incorporated | Inhibitors of IMPDH enzyme |
JP4327910B2 (ja) | 1997-03-14 | 2009-09-09 | バーテックス ファーマシューティカルズ インコーポレイテッド | Impdh酵素のインヒビター |
AR012634A1 (es) | 1997-05-02 | 2000-11-08 | Sugen Inc | Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion |
US6187799B1 (en) | 1997-05-23 | 2001-02-13 | Onyx Pharmaceuticals | Inhibition of raf kinase activity using aryl ureas |
CA2294898A1 (en) | 1997-07-03 | 1999-01-14 | Neurogen Corporation | Certain diarylimidazole derivatives; a new class of npy specific ligands |
SI9700186B (sl) * | 1997-07-14 | 2006-10-31 | Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. | Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin |
FR2766822B1 (fr) | 1997-07-30 | 2001-02-23 | Adir | Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
GB9716557D0 (en) | 1997-08-06 | 1997-10-08 | Glaxo Group Ltd | Benzylidene-1,3-dihydro-indol-2-one derivatives having anti-cancer activity |
US6022884A (en) | 1997-11-07 | 2000-02-08 | Amgen Inc. | Substituted pyridine compounds and methods of use |
US6204467B1 (en) | 1998-03-24 | 2001-03-20 | Ford Global Technologies, Inc. | Method and apparatus for resistive welding |
HUP0102058A3 (en) | 1998-05-22 | 2002-05-28 | Smithkline Beecham Corp | Novel 2-alkyl substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and their use |
US6420555B1 (en) | 1998-06-16 | 2002-07-16 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Imidazolyl derivatives |
FR2780973B1 (fr) | 1998-07-09 | 2001-10-05 | Hoechst Marion Roussel Inc | Procede de preparation du 4-(3-pyridinyl)-1h-imidazole, et les intermediaires mis en oeuvre |
DE19834751A1 (de) | 1998-08-01 | 2000-02-03 | Boehringer Ingelheim Pharma | Disubstituierte bicyclische Heterocyclen, ihre Herstellung und ihre Verwendung als Arzneimittel |
US6211177B1 (en) | 1998-11-24 | 2001-04-03 | Cell Pathways, Inc. | Method for treating neoplasia by exposure to substituted 2-aryl-benzimidazole derivatives |
ME00275B (me) | 1999-01-13 | 2011-02-10 | Bayer Corp | ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE |
IL145748A0 (en) | 1999-04-12 | 2002-07-25 | Aventis Pharma Ltd | Substituted bicyclic heteroaryl compounds as integrin antagonists |
ATE323482T1 (de) | 1999-07-02 | 2006-05-15 | Stuart A Lipton | Verwendung von p38 mapk inhibitoren in der behandlung von augenkrankheiten |
US7235658B2 (en) | 2000-03-06 | 2007-06-26 | Smithkline Beecham P.L.C. | Imidazol derivatives as Raf kinase inhibitors |
WO2001072712A1 (en) | 2000-03-24 | 2001-10-04 | Cor Therapeutics, Inc. | ISOQUINOLONE INHIBITORS OF FACTOR Xa |
WO2001072708A2 (en) | 2000-03-24 | 2001-10-04 | Cor Therapeutics, Inc. | OXINDOLE INHIBITORS OF FACTOR Xa |
JP2001322903A (ja) | 2000-05-15 | 2001-11-20 | Kumiai Chem Ind Co Ltd | 農園芸用殺菌剤組成物 |
JP2004505061A (ja) * | 2000-07-27 | 2004-02-19 | ファルマシア・コーポレーション | うっ血性心不全の処置のための、エポキシ−ステロイド型アルドステロン拮抗薬とカルシウムチャンネル遮断薬の併用療法 |
WO2002018654A1 (en) | 2000-08-30 | 2002-03-07 | The Board Of Trustees Of The University Of Arkansas | Induction of ldl receptor expression by extracellular-signal regulated kinase, erk-1/2 |
JP4734705B2 (ja) | 2000-10-31 | 2011-07-27 | 三菱化学株式会社 | リチウム二次電池用正極材料、リチウム二次電池用正極及びリチウム二次電池 |
DE10060292A1 (de) | 2000-12-05 | 2002-06-20 | Aventis Pharma Gmbh | Verwendung substituierter Benzimidazole zur Herstellung eines Medikaments zur Behandlung von Krankheiten, welche durch Inhibierung des Na+/H+-Austauschers beeinflusst werden können und sie enthaltendes Medikament |
ATE375983T1 (de) | 2000-12-15 | 2007-11-15 | Vertex Pharma | Bakterielle gyrase-hemmer und deren verwendung |
TW593278B (en) | 2001-01-23 | 2004-06-21 | Wyeth Corp | 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
CA2435820A1 (en) * | 2001-02-08 | 2002-08-15 | Karo Bio Ab | Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands |
US20050038022A1 (en) * | 2001-03-26 | 2005-02-17 | Unisearch Limited | Method for treatment of cancer and compositions for use therein |
HUP0303829A3 (en) | 2001-04-16 | 2006-02-28 | Tanabe Seiyaku Co | Large conductance calcium-acitvated k channel opener compounds, use thereof and pharmaceutical compositions containing them |
US6855714B2 (en) | 2001-07-06 | 2005-02-15 | Schering Aktiengesellschaft | 1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives |
WO2003024899A2 (en) | 2001-09-17 | 2003-03-27 | Bristol-Myers Squibb Company | CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) |
WO2003030902A1 (en) | 2001-10-09 | 2003-04-17 | Tularik Inc. | Imidazole derivates as anti-inflammatory agents |
US7039413B2 (en) * | 2001-10-24 | 2006-05-02 | Ntt Docomo, Inc. | Mobile station transfer control system, cell transfer control method, mobile station, cell transfer control method at mobile station, cell transfer control program, control apparatus, and allocating method of communication resources |
TW200300140A (en) | 2001-11-14 | 2003-05-16 | Novartis Ag | Organic compounds |
TW200303742A (en) | 2001-11-21 | 2003-09-16 | Novartis Ag | Organic compounds |
UA83620C2 (ru) * | 2001-12-05 | 2008-08-11 | Уайт | Замещенные бензоксазолы и их аналоги как эстрогенные агенты |
JP4136395B2 (ja) | 2002-02-22 | 2008-08-20 | クミアイ化学工業株式会社 | 農園芸用殺菌剤組成物 |
US8299108B2 (en) * | 2002-03-29 | 2012-10-30 | Novartis Ag | Substituted benzazoles and methods of their use as inhibitors of raf kinase |
IL164302A0 (en) * | 2002-03-29 | 2005-12-18 | Chiron Corp | Substituted benzazoles and use thereof as raf kinase inhibitors |
EP1505067A4 (en) | 2002-04-25 | 2006-06-21 | Teijin Ltd | 4,4-DISUBSTITUTED PIPERIDINE DERIVATIVES WITH CCR3 ANTAGONISM |
TW200400816A (en) * | 2002-06-26 | 2004-01-16 | Lilly Co Eli | Tricyclic steroid hormone nuclear receptor modulators |
AR040847A1 (es) | 2002-08-09 | 2005-04-20 | Astrazeneca Ab | 1,2,4-oxadiazoles como moduladores de receptores de glutamato metabotropicos, para el tratamiento de desordenes neurologicos y psiquiatricos |
ES2325687T3 (es) * | 2002-09-18 | 2009-09-14 | Pfizer Products Inc. | Compuestos de imidazol novedosos como inhibidores del factor de crecimiento transformante (tgf). |
WO2004035056A1 (en) | 2002-10-13 | 2004-04-29 | Neurosearch A/S | Use of skca channel blocking drugs for combating parkinson's disease |
WO2004035740A2 (en) | 2002-10-15 | 2004-04-29 | Synta Pharmaceuticals Corp. | Aromatic bicyclic heterocyles to modulate 1l - 12 production |
US20050054705A1 (en) * | 2003-02-04 | 2005-03-10 | Aventis Pharma Deutschland Gmbh | N-substituted (benzoimidazol-2-yl) phenylamines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them |
US7531553B2 (en) * | 2003-03-21 | 2009-05-12 | Amgen Inc. | Heterocyclic compounds and methods of use |
EP2258365B1 (en) * | 2003-03-28 | 2013-05-29 | Novartis Vaccines and Diagnostics, Inc. | Use of organic compounds for immunopotentiation |
RU2374241C2 (ru) | 2003-05-20 | 2009-11-27 | Новартис Аг | N-ацилированные азотсодержащие гетероциклические соединения в качестве лигандов ppar-рецепторов, активируемых пролифератором пероксисомы |
AU2004251641A1 (en) | 2003-05-29 | 2005-01-06 | Synta Pharmaceuticals, Corp | Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
BRPI0412380A (pt) | 2003-07-08 | 2006-09-19 | Novartis Ag | compostos de benzenossulfonilamino e composições farmacêuticas que contêm esses compostos |
JP2007502298A (ja) | 2003-08-14 | 2007-02-08 | スミスクライン ビーチャム コーポレーション | 化合物 |
JP4638436B2 (ja) | 2003-09-26 | 2011-02-23 | エグゼリクシス, インコーポレイテッド | c−Metモジュレーターおよびその使用 |
KR20060118472A (ko) * | 2003-10-16 | 2006-11-23 | 카이론 코포레이션 | 치환 벤자졸 및 raf 키나아제의 저해제로서 그것의 사용 |
CA2553433A1 (en) | 2004-01-23 | 2005-08-11 | Amgen Inc. | Quinoline quinazoline pyridine and pyrimidine compounds and their use in the treatment of inflammation angiogenesis and cancer |
TWI387592B (zh) * | 2005-08-30 | 2013-03-01 | Novartis Ag | 經取代之苯并咪唑及其作為與腫瘤形成相關激酶之抑制劑之方法 |
JP2009544617A (ja) * | 2006-07-21 | 2009-12-17 | ノバルティス アクチエンゲゼルシャフト | ベンゾイミダゾリルピリジルエーテルの製剤 |
-
2006
- 2006-08-29 TW TW095131916A patent/TWI387592B/zh not_active IP Right Cessation
- 2006-08-29 TW TW095131838A patent/TW200804345A/zh unknown
- 2006-08-29 PE PE2006001050A patent/PE20070427A1/es not_active Application Discontinuation
- 2006-08-29 PE PE2006001051A patent/PE20070335A1/es not_active Application Discontinuation
- 2006-08-30 EA EA200800441A patent/EA014230B1/ru not_active IP Right Cessation
- 2006-08-30 AU AU2006287688A patent/AU2006287688B2/en active Active
- 2006-08-30 AT AT06790127T patent/ATE503751T1/de active
- 2006-08-30 GE GEAP200610552A patent/GEP20105004B/en unknown
- 2006-08-30 RS RS20110583A patent/RS52099B/en unknown
- 2006-08-30 NZ NZ565451A patent/NZ565451A/en not_active IP Right Cessation
- 2006-08-30 BR BRPI0615309-7A patent/BRPI0615309B1/pt not_active IP Right Cessation
- 2006-08-30 WO PCT/US2006/034088 patent/WO2007030377A1/en active Application Filing
- 2006-08-30 EP EP06824870A patent/EP1926722B1/en active Active
- 2006-08-30 KR KR1020087005201A patent/KR20080039964A/ko active IP Right Grant
- 2006-08-30 WO PCT/US2006/034112 patent/WO2007027950A1/en active Application Filing
- 2006-08-30 SI SI200631203T patent/SI1926722T1/sl unknown
- 2006-08-30 AR ARP060103801A patent/AR057109A1/es unknown
- 2006-08-30 AR ARP060103802A patent/AR055622A1/es unknown
- 2006-08-30 PT PT06790127T patent/PT1924577E/pt unknown
- 2006-08-30 DK DK06790127.2T patent/DK1924577T3/da active
- 2006-08-30 DK DK06824870.7T patent/DK1926722T3/da active
- 2006-08-30 AU AU2006284666A patent/AU2006284666B2/en not_active Ceased
- 2006-08-30 NI NI200800060A patent/NI200800060A/es unknown
- 2006-08-30 SM SM200800022T patent/SMAP200800022A/it unknown
- 2006-08-30 SI SI200631026T patent/SI1924577T1/sl unknown
- 2006-08-30 KR KR1020087005202A patent/KR20080039965A/ko active IP Right Grant
- 2006-08-30 NZ NZ565450A patent/NZ565450A/en not_active IP Right Cessation
- 2006-08-30 ES ES06824870T patent/ES2374451T3/es active Active
- 2006-08-30 GT GT200600394A patent/GT200600394A/es unknown
- 2006-08-30 MY MYPI20080095A patent/MY163886A/en unknown
- 2006-08-30 US US11/513,745 patent/US20070049622A1/en not_active Abandoned
- 2006-08-30 JP JP2008529291A patent/JP5210867B2/ja not_active Expired - Fee Related
- 2006-08-30 JP JP2008529285A patent/JP5210866B2/ja active Active
- 2006-08-30 EP EP06790127A patent/EP1924577B1/en active Active
- 2006-08-30 DE DE602006021036T patent/DE602006021036D1/de active Active
- 2006-08-30 CA CA002619966A patent/CA2619966A1/en not_active Abandoned
- 2006-08-30 BR BRPI0615314-3A patent/BRPI0615314A2/pt not_active IP Right Cessation
- 2006-08-30 PL PL06790127T patent/PL1924577T3/pl unknown
- 2006-08-30 US US11/513,959 patent/US7482367B2/en active Active
- 2006-08-30 PT PT06824870T patent/PT1926722E/pt unknown
- 2006-08-30 AT AT06824870T patent/ATE526325T1/de active
- 2006-08-30 PL PL06824870T patent/PL1926722T3/pl unknown
- 2006-08-30 CA CA2620472A patent/CA2620472C/en active Active
- 2006-08-30 MY MYPI20080108A patent/MY148694A/en unknown
-
2008
- 2008-01-28 IL IL189080A patent/IL189080A/en not_active IP Right Cessation
- 2008-02-03 IL IL189194A patent/IL189194A/en not_active IP Right Cessation
- 2008-02-07 CR CR9716A patent/CR9716A/es not_active Application Discontinuation
- 2008-02-21 EC EC2008008210A patent/ECSP088210A/es unknown
- 2008-02-25 EC EC2008008218A patent/ECSP088218A/es unknown
- 2008-02-25 CU CU20080027A patent/CU23784B7/es not_active IP Right Cessation
- 2008-02-28 TN TNP2008000089A patent/TNSN08089A1/en unknown
- 2008-02-28 HN HN2008000317A patent/HN2008000317A/es unknown
- 2008-02-28 TN TNP2008000088A patent/TNSN08088A1/en unknown
- 2008-03-11 MA MA30737A patent/MA29915B1/fr unknown
- 2008-03-11 MA MA30738A patent/MA29772B1/fr unknown
- 2008-03-26 NO NO20081476A patent/NO20081476L/no not_active Application Discontinuation
- 2008-05-05 US US12/151,995 patent/US7767820B2/en not_active Expired - Fee Related
- 2008-07-24 HK HK08108224.3A patent/HK1117519A1/xx not_active IP Right Cessation
- 2008-07-25 HK HK08108275.1A patent/HK1117523A1/xx not_active IP Right Cessation
- 2008-12-05 US US12/315,779 patent/US7732465B2/en active Active
-
2010
- 2010-04-13 US US12/759,578 patent/US8592459B2/en active Active
- 2010-06-18 US US12/818,971 patent/US20100256375A1/en not_active Abandoned
-
2011
- 2011-04-29 HR HR20110312T patent/HRP20110312T1/hr unknown
- 2011-06-27 CY CY20111100607T patent/CY1111871T1/el unknown
- 2011-12-06 CY CY20111101214T patent/CY1112157T1/el unknown
- 2011-12-15 HR HR20110939T patent/HRP20110939T1/hr unknown
-
2012
- 2012-12-03 JP JP2012264553A patent/JP2013060458A/ja active Pending
- 2012-12-03 JP JP2012264552A patent/JP2013060457A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1111871T1 (el) | Υποκατεστημενα βενζιμιδαζολια και μεθοδοι παρασκευης | |
MX2012003539A (es) | Derivados de indol como moduladores de los canales de calcio activados por la liberacion de calcio (crac). | |
CY1112495T1 (el) | Κυτταροτοξικοι παραγοντες που περιλαμβανουν νεα παραγωγα τομαϋμυκινης | |
HK1119699A1 (en) | Pyridopyrimidinone inhibitors of pi3kalpha | |
CY1116885T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου | |
CY1110835T1 (el) | Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c | |
EA200801428A1 (ru) | Производные пиридиазинона для лечения опухолей | |
EA201200669A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
CY1114793T1 (el) | Παραγωγα αμινοπυραζολιου | |
MA32544B1 (fr) | Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique | |
CY1110034T1 (el) | Παραγωγα 1,2,4,5-τετραϋδρο-3h-βενζαζεπινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν | |
BRPI0412999A (pt) | 2-aminotetralina substituìda para tratamento de depressão | |
NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
ATE478054T1 (de) | Benzimidazolderivate | |
EA201070281A1 (ru) | Производные индол-2-она, двузамещенные в положении 3, их получение и их применение в терапии | |
ATE488510T1 (de) | Heterocyclische derivate, deren herstellung und therapeutische verwendung | |
CY1111432T1 (el) | Τετραϋδροκινολινες για χρηση ως διαμορφωτες της μιτοτικης κινητικης πρωτεϊνης eg5 | |
TW200738697A (en) | Benzimidazole derivatives as 5-HT6,5-HT24 | |
NO20044548L (no) | Fremgangsmate for fremstilling av 6-alkaliden-penemderivater | |
UA86873C2 (en) | SUBSTITUTED ARYL 1,4-PYRAZlNE DERIVATIVES | |
FR2894579B1 (fr) | Derives diaryltriazolmethylamine, leur preparation et leur application en therapeutique. | |
CY1110944T1 (el) | Νεα παραγωγα κυκλοαλκυλιωμενων βενζοθειαδιαζινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν | |
CY1114798T1 (el) | Ενωσεις σουλφοναμιδιου για τη θεραπευτικη αντιμετωπιση αναπνευστικων διαταραχων | |
ATE456572T1 (de) | Verfahren zum herstellen von lysobactin-derivaten | |
CR8955A (es) | Hexadecasacaridos biotinilados, su preparacion y su utilizacion |